Thursday, August 28, 2014
Inquirer Daily News

Archive: April, 2010

Hospitals tout economic impact on region

Friday, April 30, 2010, 8:37 AM
The Delaware Valley Healthcare Council, the local chapter of Pennsylvania’s hospital association, is urging state and federal lawmakers to boost health spending to sustain the economic benefits of hospitals here. A report from the group claimed that hospitals here are “primary economic... Read more

Not so dandy candy

Friday, April 30, 2010, 5:31 PM
As a parent of a 3-year-old who is much more interested in “treats” than dinner, I know that anything that looks like candy within my daughter’s reach is likely to end up in her mouth. That’s bad for many reasons, but a piece by my colleague Sandy Bauers in the Health &... Read more

Blue Cross to pump an extra $47 million a year into primary care

Thursday, April 29, 2010, 8:44 AM
Independence Blue Cross, the region's largest health insurer, plans to boost payments to primary care doctors by $47 million a year directed toward practices that improve quality and meet certain efficiency goals. The goal is to encourage primary care doctors to deliver higher quality and more efficient... Read more

Prostate cancer vaccine approved

Thursday, April 29, 2010, 5:26 PM
The FDA approved the first ever cancer vaccine Thursday. Provenge made by Dendreon Corp. of Seattle, Wash. is for men with advanced prostate cancer. The vaccine uses the male immune system to fight tumors. The FDA said Provenge is for “asymptomatic or minimally symptomatic prostate cancer”... Read more

Want to avoid medical errors? Don’t interrupt the nurse

Wednesday, April 28, 2010, 1:41 PM
Nurses who are interrupted as they attempt to administer medications to hospitalized patients are significantly more prone to medical errors, according to a study at two major teaching hospitals in Sydney, Australia. Researchers from the University of New South Wales and the University of Sydney observed... Read more

AstraZeneca paid docs to prescribe drug, government alleged

Wednesday, April 28, 2010, 9:39 AM
Tucked in the $520 million settlement agreement between AstraZeneca and the federal government over the drugmaker's alleged improper marketing of its antipsychotic drug Seroquel was the charge that the company paid doctors to study the drug, speak about it, and lend their names to ghostwritten articles... Read more

Please pass the chocolate I feel mood coming on

Tuesday, April 27, 2010, 11:30 AM
Chocolate is the well known cure-all for the depressed, whether it's because of a breakup, job loss or other tragedy. The food is so deeply ingrained in the culture that we rarely give much thought to the question of whether there is a medical reason for the apparent link between eating chocolate and... Read more

A potentially dangerous drug combo

Tuesday, April 27, 2010, 8:31 AM
Two commonly prescribed drugs that don’t go well together are Plavix, the anti-blood clotting medication often taken by heart patients, and Nexium, a so-called proton pump inhibitor given for heart burn. A study in the current issue of the Archives of Internal Medicine found that patients who... Read more

AstraZeneca to pay $520 million settlement in anti-psychotic drug case

Tuesday, April 27, 2010, 3:27 PM
AstraZeneca, the British drugmaker with its American headquarters in Wilmington, Del., has agreed to a $520 million civil settlement over allegations that it illegally marketed its antipsychotic drug Seroquel for uses that were not approved by the U.S. Food and Drug Administration. U.S. Attorney General... Read more

Hold the sugar

Monday, April 26, 2010, 1:20 PM
I’ll admit it; I am a sucker for processed food. Put a bag of ships or communal candy nearby and I simply can’t resist. Just this morning, I grabbed a couple of chocolate-chip cookies that a kindly colleague put out for public consumption. This sweet tooth has made it difficult to lose... Read more
About this blog

Check Up covers major health events in our region and offers everything from personal health advice to an expert look at health reform. Read about some of our bloggers here.

For Inquirer.com. Portions of this blog may also be found in the Inquirer's Sunday Health Section

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Also on Philly.com:
Stay Connected